Sfoglia per Autore
Synthesis and Biological Evaluation of Nonpeptide alpha-v-beta-3/alpha-5-beta-1 Integrin Dual Antagonists containing 5,6-Dihydropyridin-2-one Scaffolds
2007 F. Benfatti; G. Cardillo; S.Fabbroni; P. Galzerano; L. Gentilucci; R. Juris; A. Tolomelli; M. Baiula; A. Spartà; S.Spampinato
Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics.
2007 Gentilucci L.; Cardillo G. ; Squassabia F.; Tolomelli A.; Spampinato S.; Sparta A.; Baiula M.
New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alpha(L)beta(2) and alpha(M)beta(2).
2008 Bucolo C.; Maltese A.; Maugeri F.; Ward K.W.; Baiula M.; Spartà A.; Spampinato S.
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine
2008 Ahmed R. Qasem, Claudio Bucolo, Monica Baiula, Antonino Spartà, Paolo Govoni, Andrea Bedini, Domenico Fascì, Santi Spampinato
β-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist
2010 Spartà A; Baiula M; Campbell G; Spampinato S.
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
2011 Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
2013 C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M. Spartà; J. A. McCubrey; A.M. Martelli.
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia.
2014 A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli.
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.
2015 Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Synthesis and Biological Evaluation of Nonpeptide alpha-v-beta-3/alpha-5-beta-1 Integrin Dual Antagonists containing 5,6-Dihydropyridin-2-one Scaffolds | F. Benfatti; G. Cardillo; S.Fabbroni; P. Galzerano; L. Gentilucci; R. Juris; A. Tolomelli; M. Bai...ula; A. Spartà; S.Spampinato | 2007-01-01 | BIOORGANIC & MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. | Gentilucci L.; Cardillo G. ; Squassabia F.; Tolomelli A.; Spampinato S.; Sparta A.; Baiula M. | 2007-01-01 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - | 1.01 Articolo in rivista | - |
New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alpha(L)beta(2) and alpha(M)beta(2). | Bucolo C.; Maltese A.; Maugeri F.; Ward K.W.; Baiula M.; Spartà A.; Spampinato S. | 2008-01-01 | JOURNAL OF PHARMACY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine | Ahmed R. Qasem, Claudio Bucolo, Monica Baiula, Antonino Spartà, Paolo Govoni, Andrea Bedini, Dome...nico Fascì, Santi Spampinato | 2008-01-01 | BIOCHEMICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
β-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist | Spartà A; Baiula M; Campbell G; Spampinato S. | 2010-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist | Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S | 2011-01-01 | MOLECULAR VISION | - | 1.01 Articolo in rivista | - |
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. | C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M.... Spartà; J. A. McCubrey; A.M. Martelli. | 2013-01-01 | EXPERT OPINION ON THERAPEUTIC TARGETS | - | 1.01 Articolo in rivista | - |
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. | A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti...; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli. | 2014-01-01 | CELL CYCLE | - | 1.01 Articolo in rivista | - |
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. | Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buo...ntempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli | 2015-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | PI3K pan inhibition impairs more efficiently proliferation and survival of T cell acute lymphoblastic leukemia cell lines when compared to isoform selective PI3K inhibitors..pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile